Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Single Ultrasound-Guided Dextrose Prolotherapy Plus Therapeutic Exercise for Subacromial-Subdeltoid Bursitis: A Pilot Double-Blind Randomized Controlled Trial.

Created on 03 Oct 2026

Authors

Ru-Lan Hsieh, Wen-Chung Lee, Wei-Min Chiu

Published in

Archives of physical medicine and rehabilitation. Oct 02, 2026. Epub Oct 02, 2026.

Abstract

To determine whether a single ultrasound-guided dextrose prolotherapy (DPT) injection added to supervised therapeutic exercise improves outcomes versus saline injection plus the same program in adults with subacromial-subdeltoid (SASD) bursitis.
Pilot double-blind randomized controlled trial with 13-week follow-up.
Tertiary referral hospital in XXXXX.
Adults aged ≥20 years with ultrasound-confirmed SASD bursitis and shoulder pain ≤3 months were randomized (n=46; 23 per group); 42 completed 13-week follow-up.
Participants received one ultrasound-guided SASD bursal injection of 10 mL 20% dextrose or 10 mL normal saline, followed by a standardized 12-week therapeutic exercise program delivered 3 times weekly.
The primary outcome was Shoulder Pain and Disability Index (SPADI) total score. Secondary outcomes included SPADI subscales, Disabilities of the Arm, Shoulder and Hand (DASH), visual analog scale (VAS) pain, shoulder range of motion (ROM), and World Health Organization Quality of Life-Brief (WHOQOL-BREF). Treatment effects were assessed by sex- and baseline-adjusted repeated-measures analysis of covariance using the group × time interaction.
SPADI total score showed a more favorable longitudinal trajectory with DPT+exercise than saline+exercise (group × time p=.004). At 13 weeks, the observed unadjusted between-group difference was -6.40 points (95% CI, -8.72 to -4.08), below the prespecified 8-point minimal clinically important difference. Significant group × time interactions also favored DPT+exercise for SPADI pain (p=.002) and disability (p=.017), active abduction (p<.001) and external rotation (p=.012), passive external rotation (p=.002) and internal rotation (p=.016), and VAS pain (p=.001). DASH and WHOQOL-BREF showed no differential longitudinal effects.Four DPT participants reported transient postinjection soreness; no serious adverse events occurred.
Adding a single ultrasound-guided DPT injection to therapeutic exercise produced more favorable longitudinal changes in SPADI total score, selected ROM measures, and pain than saline injection plus exercise and was well tolerated. Larger trials with longer follow-up are warranted.

PMID:
42826813
Bibliographic data and abstract were imported from PubMed on 03 Oct 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 20
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement